Arq. Bras. Oftalmol. 2021; 84 (3): 10.5935/0004-2749.20210042
Total: 2753
Rosalia Antunes-Foschini1; Leidiane Adriano1; Adriana de Andrade Batista Murashima1; Amanda Pires Barbosa1; Luis Fernando Nominato1; Lara Cristina Dias1; Marina Zilio Fantucci1; Denny Marcos Garcia1; Monica Alves2; Eduardo Melani Rocha1
DOI: 10.5935/0004-2749.20210042
1. Department of Ophthalmology, Otorhinolaryngology and Head and Neck Surgery, Faculdade de Medicina de Ribeirão, Universidade de São Paulo, Ribeirão Preto, SP, Brazil
2. Discipline of Ophthalmology and Otorhinolaryngology, Faculdade de Ciências Médicas, Universidade Estadual de Campinas, Campinas, SP, Brazil
Eduardo Melani Rocha
E-mail: [email protected]
Disclosure of potential conflicts of interest: Eduardo Melani Rocha has applied for a patent for an insulin eye drop delivery system. No other competing financial interests exist among the authors. The other authors have no potential conflicts of interest to disclose.
How to cite this article:
ABO is licensed under a Creative Commons Attribution-NonComercial 4.0 Internacional.
